Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apixaban vs Warfarin for Post-operative Atrial Fibrillation
NCT02889562Phase 3Completed
- Sponsor
- Sanford Health
- Start
- Sep 2016
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of apixaban in Atrial fibrillation (AFib), sponsored by Sanford Health. Started Sep 2016; status: completed.
02
Drugs
apixaban
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT02889562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02889562.